Next Generation Rocklatan
Completed · Phase 2 · Has a placebo group
Conditions studied: Open Angle Glaucoma, Ocular Hypertension
In brief
The purpose of this two-stage clinical trial is to assess the safety and hypotensive efficacy of AR-17043 and PG043 ophthalmic solutions in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT).
Key facts
- Study ID
- NCT06441643
- Run by
- Alcon Research
- People needed
- 426
- Starts
- 2024-09-04
- Expected to finish
- 2025-11-14
- Last updated by the study team
- 2025-11-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Orange County Ophthalmology Medical Group — Garden Grove, California, United States
- United Medical Research Institute — Inglewood, California, United States
- Eye Research Foundation — Newport Beach, California, United States
- North Bay Eye Associates — Petaluma, California, United States
- Eye Center of Northern Colorado, PC — Fort Collins, Colorado, United States
- Coastal Research Associates — Roswell, Georgia, United States
- Rochester Ophthalmological Group — Rochester, New York, United States
- James D. Branch Ophthalmology — Winston-Salem, North Carolina, United States
- Scott & Christie and Associates, PC — Cranberry Township, Pennsylvania, United States
- University Eye Specialists — Maryville, Tennessee, United States
- Total Eye Care PA — Memphis, Tennessee, United States
- Piedmont Eye Center — Lynchburg, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.